FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1213.109

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113762.1.4.1213.109
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1213.109/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.109
Version20231215
Statusactive
Date2023-12-15T19:18:20-05:00
NameOralAnticoagulantIngredientsAndRiskOfGIBleeding
TitleOral Anticoagulant Ingredients and Risk of GI Bleeding
Realmus
Authorityhl7
Purpose(Clinical Focus: The purpose of this value set is to represent concepts for oral anticoagulants at an ingredietn level and identified products containing those: warfarin, apixaban, edoxaban, dabigatran and rivaroxaban),(Data Element Scope: This value uses the corresponding RxCui for each ingredient of interest),(Inclusion Criteria: Includes concepts that describe oral anticoagulants),(Exclusion Criteria: Excludes concepts that describe branded and non-prescribable oral anticoagulants)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1213.109",
  "meta": {
    "versionId": "9",
    "lastUpdated": "2023-12-15T19:18:20.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "Meaningful Drug Interaction Alerts Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2023-12-15"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2023-12-15"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.109",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1213.109"
    }
  ],
  "version": "20231215",
  "name": "OralAnticoagulantIngredientsAndRiskOfGIBleeding",
  "title": "Oral Anticoagulant Ingredients and Risk of GI Bleeding",
  "status": "active",
  "date": "2023-12-15T19:18:20-05:00",
  "publisher": "Meaningful Drug Interaction Alerts Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for oral anticoagulants at an ingredietn level and identified products containing those: warfarin, apixaban, edoxaban, dabigatran and rivaroxaban),(Data Element Scope: This value uses the corresponding RxCui for each ingredient of interest),(Inclusion Criteria: Includes concepts that describe oral anticoagulants),(Exclusion Criteria: Excludes concepts that describe branded and non-prescribable oral anticoagulants)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "1037042",
            "display": "dabigatran etexilate"
          },
          {
            "code": "1114195",
            "display": "rivaroxaban"
          },
          {
            "code": "11289",
            "display": "warfarin"
          },
          {
            "code": "1364430",
            "display": "apixaban"
          },
          {
            "code": "1546356",
            "display": "dabigatran"
          },
          {
            "code": "1599538",
            "display": "edoxaban"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:dc82a96a-4174-4111-93a1-7df40af5b873",
    "timestamp": "2025-05-23T19:20:21-04:00",
    "total": 6,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1037042",
        "display": "dabigatran etexilate"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1114195",
        "display": "rivaroxaban"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "11289",
        "display": "warfarin"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1364430",
        "display": "apixaban"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1546356",
        "display": "dabigatran"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1599538",
        "display": "edoxaban"
      }
    ]
  }
}